Nath Bio-Genes (I) Ltd (NATHBIOGEN) share fundamentals
Nath Bio-Genes (I) Ltd is a micro-cap company in Consumer Staples (Agro Products) with a market capitalisation of ₹257 crore. Here is where it stands on valuation, profitability, debt and growth as of 5 November 2026, and how it compares with the median Consumer Staples company.
Financial health score
Out of 100, across five pillars of reported fundamentals.
What stands out
- Low debt (D/E 0.20x)
- 6.3% promoter stake pledged
- Negative free cash flow
- Revenue up 24% YoY
Nath Bio-Genes (I) Ltd vs the Consumer Staples median
| Metric | NATHBIOGEN | Sector median | |
|---|---|---|---|
| PE ratioprice paid for each rupee of yearly profit | 7.08x | 15.18x | Better |
| Price to bookprice against the book value of assets | 0.38x | 1.61x | Better |
| EV / EBITDAbusiness value against operating profit | 4.8x | 11.91x | Better |
| Dividend yieldyearly dividend as a share of price | 1.5% | 0.8% | Better |
| Return on equityprofit on shareholders’ money | 6.3% | 9.3% | Weaker |
| ROCEprofit on all capital employed | 8.9% | 12.5% | Weaker |
| Net profit marginprofit kept from each rupee of sales | 9.1% | 3.6% | Better |
| Debt to equityborrowing against shareholders’ money | 0.2x | 0.31x | Better |
| Interest coveragehow many times profit covers interest | 3.86x | 4.15x | In line |
| Current ratioshort-term assets against short-term dues | 1.97x | 1.87x | In line |
| Revenue growth (1Y)change in sales over a year | 24% | 9.7% | Better |
| EPS growth (1Y)change in earnings per share over a year | 7.9% | 5.2% | Better |
| Promoter holdingshare owned by the founders or parent | 45.6% | 59.8% | Weaker |
| Promoter pledgepromoter shares pledged as loan security | 6.3% | 0% | Weaker |
| Betahow much it moves with the market | 1.69 | 0.88 | |
| 1-year returnshare price change over 52 weeks | -17.9% | -17% |
Tell DecideChart your amount, timeline and target return, and AI builds a full A4 report with risks, scenarios and worst cases. Your first report is free.
Other Consumer Staples companies
Hindustan Unilever LtdHINDUNILVR · score 73.8
ITC LtdITC · score 70.9
Nestle India LtdNESTLEIND · score 67.7
Varun Beverages LimitedVBL · score 75
Britannia Industries LtdBRITANNIA · score 67.1
Marico LimitedMARICO · score 71.7
Tata Consumer Products LtdTATACONSUM · score 59.6
United Spirits LimitedUNITDSPR · score 74.5
Godrej Consumer Products LtdGODREJCP · score 60.8
Dabur India LimitedDABUR · score 73.2
Radico Khaitan LimitedRADICO · score 74.7
Cupid LtdCUPID · score 77.3Frequently asked questions
What is the PE ratio of Nath Bio-Genes (I) Ltd?
Nath Bio-Genes (I) Ltd trades at a PE of 7.08x as of 5 November 2026, against a Consumer Staples median of 15.18x. PE is the price paid for each rupee of yearly profit.
Is Nath Bio-Genes (I) Ltd debt free?
No. Nath Bio-Genes (I) Ltd has a debt-to-equity ratio of 0.2x, against a Consumer Staples median of 0.31x.
What is the ROCE and ROE of Nath Bio-Genes (I) Ltd?
Nath Bio-Genes (I) Ltd has a return on capital employed of 8.9% and a return on equity of 6.3%. The Consumer Staples medians are 12.5% and 9.3%.
What is the DecideChart health score of Nath Bio-Genes (I) Ltd?
Nath Bio-Genes (I) Ltd scores 77.6 out of 100, graded Healthy. The score weighs profitability, debt, valuation, growth and governance from the company’s reported numbers. It is a research aid, not a recommendation.
Should I buy Nath Bio-Genes (I) Ltd shares?
DecideChart does not give buy or sell tips and is not linked to SEBI, BSE or NSE. Use these numbers for your own research, compare Nath Bio-Genes (I) Ltd with its Consumer Staples peers, and consult a SEBI-registered adviser before investing.
Fundamentals from a public market-data screener, as of 5 November 2026. Figures can lag company filings. DecideChart is AI-based, not linked to SEBI, BSE or NSE, and does not give investment advice.